TriSalus Life Sciences Inc - Warrants (04/08/2028) (TLSIW)

NASDAQ

$0.79

TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company is headquartered in Westminster, Colorado.

This company is also listed under the following ticker: TLSI.

Website: https://trisaluslifesci.com

Market Cap

$48M

Free Cash Flow Yield

-42.76%

Beta (5Y)

0.11

Price Chart

Adjust inflation

Log

Valuation

Market Cap$48M

Profitability

Total Revenue (TTM)$45M

EBITDA-$27M

Profit Margin17.3%

Operating Margin-94.5%

EPS-$0.60

Financial Health

Debt-to-Equity258.3%

Free Cash Flow Yield-42.76%

Growth & Risk

Beta (5Y)0.11

Sharpe Ratio2.72